Key result
Remdesivir (Rem-P3) bound to the SARS-CoV-2 RdRp-NSP complex with higher affinity (ΔGbind -33.4 kcal/mol) than ATP (-20.5 kcal/mol) and induced structural disintegration of the replicative machinery.
Why the study?
Disrupting viral RNA replication is a key strategy against SARS-CoV-2, prompting molecular modeling of remdesivir binding to the RdRp-NSPs complex.
Absolute Event Rate: -33.4% vs -20.5%
Computational modeling suggests Remdesivir disrupts the SARS-CoV-2 RNA replicative machinery by disintegrating the RdRp-NSP complex.
Hypothesis-generating for remdesivir-RdRp interactions; leaves open clinical translation pending validation.
The recently emerged SARS-like coronavirus (SARS-CoV-2) has continued to spread rapidly among humans with alarming upsurges in global mortality rates. A major key to tackling this virus is to disrupt its RNA replication process as previously reported for Remdesivir ( Rem -P 3 ). For the first time, we modeled the binding of Rem -P 3 to SARS-CoV-2 RdRp-NSPs complex, a multimeric assembly that drives viral RNA replication in human hosts. Findings revealed that while ATP -binding stabilized the replicative tripartite, Rem -P 3 disintegrated the RdRp-NSP complex, starting with the detachment of the NSP7-NSP8 heterodimer followed by minimal displacement of the second NSP8 subunit (NSP8 II ). More so, Rem -P 3 interacted with a relatively higher affinity ( ΔG bind ) while inducing high perturbations across the RdRp-NSP domains. D452, T556, V557, S682, and D760 were identified for their crucial roles in stacking the cyano-adenosine and 3,4-dihydroxyoxolan rings of Rem -P 3 while its flexible P 3 tail extended towards the palm domain blocking D618 and K798; a residue-pair identified for essential roles in RNA replication. However, ATP folded away from D618 indicative of a more coordinated binding favorable for nucleotide polymerization. We believe findings from this study will significantly contribute to the structure-based design of novel disruptors of the SARS-CoV-2 RNA replicative machinery.
No takes yet. Share an insight, caveat, or question.
Olotu et al. (2020) studied SARS-CoV-2. Remdesivir (Rem-P3) vs. ATP was evaluated on Binding free energy (ΔGbind) in kcal/mol. Remdesivir (Rem-P3) bound to the SARS-CoV-2 RdRp-NSP complex with higher affinity (ΔGbind -33.4 kcal/mol) than ATP (-20.5 kcal/mol) and induced structural disintegration of the replicative machinery.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: